Anti-Recombinant-CD225/IFITM1 antibody [RM1N85] (STJA0023871)

SKU:
STJA0023871
£309.50 - £472.50
Free Shipping
Processing The item has been added

Host: Rabbit
Applications: IF/IHC/IP/WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Rabbit monoclonal antibody anti-Recombinant-Interferon-Induced Transmembrane Protein 1 is suitable for use in Immunofluorescence, Immunohistochemistry, Immunoprecipitation and Western Blot research applications.
Clonality : Monoclonal
Clone ID : RM1N85
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.01M PBS
Purification: Protein A/G purified from cell culture supernatant
Dilution Range: IF: 1:50-1:200
Storage Instruction: Suitable for storage at +4°C between 1-2 weeks. For longer term store at-20°C for up to 12 months.
Gene Symbol: IFITM1
Gene ID: 8519
Uniprot ID: IFM1_HUMAN
Post Translational Modifications Palmitoylation on membrane-proximal cysteines controls clustering in membrane compartments and antiviral activity.
Function IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronaviruses (SARS-CoV and SARS-CoV-2), Marburg virus (MARV), Ebola virus (EBOV), Dengue virus (DNV), West Nile virus (WNV), human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV). Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry and SARS-CoV and SARS-CoV-2 S protein-mediated viral entry. Also implicated in cell adhesion and control of cell growth and migration. Inhibits SARS-CoV-2 S protein-mediated syncytia formation. Plays a key role in the antiproliferative action of IFN-gamma either by inhibiting the ERK activation or by arresting cell growth in G1 phase in a p53-dependent manner. Acts as a positive regulator of osteoblast differentiation. In hepatocytes, IFITM proteins act in a coordinated manner to restrict HCV infection by targeting the endocytosed HCV virion for lysosomal degradation. IFITM2 and IFITM3 display anti-HCV activity that may complement the anti-HCV activity of IFITM1 by inhibiting the late stages of HCV entry, possibly in a coordinated manner by trapping the virion in the endosomal pathway and targeting it for degradation at the lysosome.
Protein Name Interferon-Induced Transmembrane Protein 1
Dispanin Subfamily A Member 2a
Dspa2a
Interferon-Induced Protein 17
Interferon-Inducible Protein 9-27
Leu-13 Antigen
Cd Antigen Cd225
Database Links Reactome: R-HSA-198933
Reactome: R-HSA-909733
Cellular Localisation Cell Membrane
Single-Pass Membrane Protein
Lysosome Membrane
Alternative Antibody Names Anti-Interferon-Induced Transmembrane Protein 1 antibody
Anti-Dispanin Subfamily A Member 2a antibody
Anti-Dspa2a antibody
Anti-Interferon-Induced Protein 17 antibody
Anti-Interferon-Inducible Protein 9-27 antibody
Anti-Leu-13 Antigen antibody
Anti-Cd Antigen Cd225 antibody
Anti-IFITM1 antibody
Anti-CD225 antibody
Anti-IFI17 antibody

Information sourced from Uniprot.org